These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 2843483)
61. Synthetic peptides representing epitopes of outer membrane protein F of Pseudomonas aeruginosa that elicit antibodies reactive with whole cells of heterologous immunotype strains of P. aeruginosa. Hughes EE; Gilleland LB; Gilleland HE Infect Immun; 1992 Sep; 60(9):3497-503. PubMed ID: 1379985 [TBL] [Abstract][Full Text] [Related]
62. Prophylactic and therapeutic efficacy of immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharide against murine experimental corneal infection. Preston MJ; Gerçeker AA; Koles NL; Pollack M; Pier GB Invest Ophthalmol Vis Sci; 1997 Jun; 38(7):1418-25. PubMed ID: 9191605 [TBL] [Abstract][Full Text] [Related]
63. Development of an anti-adhesive vaccine for Pseudomonas aeruginosa targeting the C-terminal region of the pilin structural protein. Sheth HB; Glasier LM; Ellert NW; Cachia P; Kohn W; Lee KK; Paranchych W; Hodges RS; Irvin RT Biomed Pept Proteins Nucleic Acids; 1995; 1(3):141-8. PubMed ID: 9346845 [TBL] [Abstract][Full Text] [Related]
65. Secretory IgA inhibits Pseudomonas aeruginosa binding to cornea and protects against keratitis. Masinick SA; Montgomery CP; Montgomery PC; Hazlett LD Invest Ophthalmol Vis Sci; 1997 Apr; 38(5):910-8. PubMed ID: 9112987 [TBL] [Abstract][Full Text] [Related]
66. Perlecan in the basement membrane of corneal epithelium serves as a site for P. aeruginosa binding. Chen LD; Hazlett LD Curr Eye Res; 2000 Apr; 20(4):260-7. PubMed ID: 10806439 [TBL] [Abstract][Full Text] [Related]
67. Monoclonal antibodies provide protection against ocular Pseudomonas aeruginosa infection. Moon MM; Hazlett LD; Hancock RE; Berk RS; Barrett R Invest Ophthalmol Vis Sci; 1988 Aug; 29(8):1277-84. PubMed ID: 2843483 [TBL] [Abstract][Full Text] [Related]